company background image
524412 logo

Aarey Drugs & Pharmaceuticals BSE:524412 Stock Report

Last Price

₹53.08

Market Cap

₹1.5b

7D

8.4%

1Y

58.3%

Updated

17 Jul, 2024

Data

Company Financials

Aarey Drugs & Pharmaceuticals Limited

BSE:524412 Stock Report

Market Cap: ₹1.5b

524412 Stock Overview

Engages in the manufacture and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India.

524412 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health3/6
Dividends0/6

Aarey Drugs & Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aarey Drugs & Pharmaceuticals
Historical stock prices
Current Share Price₹53.08
52 Week High₹68.00
52 Week Low₹30.00
Beta0.96
11 Month Change11.30%
3 Month Change12.94%
1 Year Change58.26%
33 Year Change45.62%
5 Year Change215.95%
Change since IPO116.65%

Recent News & Updates

Recent updates

Shareholder Returns

524412IN PharmaceuticalsIN Market
7D8.4%0.8%0.8%
1Y58.3%51.4%45.4%

Return vs Industry: 524412 exceeded the Indian Pharmaceuticals industry which returned 51.4% over the past year.

Return vs Market: 524412 exceeded the Indian Market which returned 45.4% over the past year.

Price Volatility

Is 524412's price volatile compared to industry and market?
524412 volatility
524412 Average Weekly Movement5.9%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 524412 has not had significant price volatility in the past 3 months.

Volatility Over Time: 524412's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1990n/aMihir Ghataliawww.aareydrugs.com

Aarey Drugs & Pharmaceuticals Limited engages in the manufacture and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1, and 3 dioxalane and uracile, as well as active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, including aromatic chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals.

Aarey Drugs & Pharmaceuticals Limited Fundamentals Summary

How do Aarey Drugs & Pharmaceuticals's earnings and revenue compare to its market cap?
524412 fundamental statistics
Market cap₹1.49b
Earnings (TTM)₹46.84m
Revenue (TTM)₹3.96b

31.8x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524412 income statement (TTM)
Revenue₹3.96b
Cost of Revenue₹3.82b
Gross Profit₹137.19m
Other Expenses₹90.36m
Earnings₹46.84m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.67
Gross Margin3.47%
Net Profit Margin1.18%
Debt/Equity Ratio23.6%

How did 524412 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.